v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance, shares at Dec. 31, 2024   5,698,231      
Beginning balance at Dec. 31, 2024 $ 22,149 $ 6 $ 537,620 $ (122) $ (515,355)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Vesting of restricted stock units (in shares)   90,514      
Vesting of restricted stock units 0        
Stock-based compensation expense 519   519    
Unrealized loss on marketable securities (6)     (6)  
Net loss 282       282
Ending balance, shares at Mar. 31, 2025   5,788,745      
Ending balance at Mar. 31, 2025 22,944 $ 6 538,139 (128) (515,073)
Beginning balance, shares at Dec. 31, 2024   5,698,231      
Beginning balance at Dec. 31, 2024 22,149 $ 6 537,620 (122) (515,355)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (25,459)        
Ending balance, shares at Jun. 30, 2025   7,959,947      
Ending balance at Jun. 30, 2025 3,971 $ 8 544,915 (138) (540,814)
Beginning balance, shares at Mar. 31, 2025   5,788,745      
Beginning balance at Mar. 31, 2025 22,944 $ 6 538,139 (128) (515,073)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Proceeds from the sale of stock, less discounts (in shares)   2,140,729      
Proceeds from the sale of common stock, less discounts 5,984 $ 2 5,982    
Issuance of shares of common stock under employee stock purchase plan (in shares)   18,473      
Issuance of common stock under employee stock purchase plan 46   46    
Vesting of restricted stock units (in shares)   12,000      
Vesting of restricted stock units 0        
Stock-based compensation expense 748   748    
Unrealized loss on marketable securities (10)     (10)  
Net loss (25,741)       (25,741)
Ending balance, shares at Jun. 30, 2025   7,959,947      
Ending balance at Jun. 30, 2025 3,971 $ 8 544,915 (138) (540,814)
Beginning balance, shares at Dec. 31, 2025   90,906,920      
Beginning balance at Dec. 31, 2025 186,290 $ 91 780,862 (109) (594,554)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Vesting of restricted stock units (in shares)   12,776      
Vesting of restricted stock units 0        
Exercise of pre-funded warrants (in shares)   3,400,000      
Exercise of pre-funded warrants 1 $ 3 (2)    
Stock-based compensation expense 2,413   2,413    
Unrealized loss on marketable securities (13)     (13)  
Net loss (20,241)       (20,241)
Ending balance, shares at Mar. 31, 2026   94,319,696      
Ending balance at Mar. 31, 2026 168,450 $ 94 783,273 (122) (614,795)
Beginning balance, shares at Dec. 31, 2025   90,906,920      
Beginning balance at Dec. 31, 2025 186,290 $ 91 780,862 (109) (594,554)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (36,398)        
Ending balance, shares at Jun. 30, 2026   96,114,534      
Ending balance at Jun. 30, 2026 155,454 $ 96 786,433 (123) (630,952)
Beginning balance, shares at Mar. 31, 2026   94,319,696      
Beginning balance at Mar. 31, 2026 168,450 $ 94 783,273 (122) (614,795)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of shares of common stock under employee stock purchase plan (in shares)   24,420      
Issuance of common stock under employee stock purchase plan 76   76    
Vesting of restricted stock units (in shares)   70,418      
Vesting of restricted stock units 0        
Exercise of pre-funded warrants (in shares)   1,700,000      
Exercise of pre-funded warrants 0 $ 2 (2)    
Stock-based compensation expense 3,086   3,086    
Unrealized loss on marketable securities (1)     (1)  
Net loss (16,157)       (16,157)
Ending balance, shares at Jun. 30, 2026   96,114,534      
Ending balance at Jun. 30, 2026 $ 155,454 $ 96 $ 786,433 $ (123) $ (630,952)